Publications by authors named "Joshua D Lee"

Claim this Profile
A
A Rare Presentation of Cryoglobulinemic Vasculitis Associated with Primary Sjögren's Syndrome.
Caroline Metyas, Joshua Donguk Lee, Jenny Ann Jun, Daniel George Arkfeld

Curr Rheumatol Rev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying patterns of withdrawal among patients in treatment for opioid use disorder: A secondary latent class growth analysis of the CTN XBOT trial.
Noel Vest, Christina E Freibott, Kelly E Dunn, Landhing Moran, P T Korthuis, Joshua D Lee

J Subst Use Addict Treat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injectable buprenorphine during transition out of prison: A pilot partially randomized preference trial protocol.
Justin Berk, Max Cook, Megan Martin, Joshua D Lee, Daphne Koinis-Mitchell

Contemp Clin Trials· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data.
Sara Lodi, Shapei Yan, Benjamin Bovell-Ammon, Paul J Christine, Heather E Hsu, Joshua D Lee

Addiction· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissemination of health content through social networks: YouTube and opioid use disorders.
Bridget O'Kelly, Perry Holmes, Anna Cheng, Joshua D Lee, Babak Tofighi

J Subst Use Addict Treat· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.
Noa Krawczyk, Sungwoo Lim, Teena Cherian, Keith S Goldfeld, Monica Katyal, Joshua D Lee

Drug Alcohol Depend· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"I Can Combine Those Things to be a Superhero" a Qualitative Study of the Motivations for High-Risk Polysubstance Use.
Amanda M Bunting, Adetayo Fawole, Brittany Griffin, Joshua D Lee, Carrie B Oser

J Drug Issues· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder.
Paul J Christine, Sara Lodi, Heather E Hsu, Benjamin Bovell-Ammon, Shapei Yan, Joshua D Lee

Addiction· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fentanyl Test Strips for Harm Reduction: A Scoping Review.
Eric Kutscher, Marco Barber Grossi, Fred LaPolla, Joshua D Lee

J Addict Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration.
Teena Cherian, Sungwoo Lim, Monica Katyal, Keith S Goldfeld, Ryan McDonald, Joshua D Lee

Drug Alcohol Depend· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of jail-initiated medication for opioid use disorder: A multisite analysis of the SOMATICS collaborative.
Joshua D Lee, Keith Goldfeld, Robert P Schwartz, Ryan McDonald, Yifan Xu, Anjalee Sharma

PLoS One· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis.
Sungwoo Lim, Teena Cherian, Monica Katyal, Keith S Goldfeld, Ryan McDonald, Joshua D Lee

J Subst Use Addict Treat· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parakinesia Brachialis Oscitans and Excessive yawning From Tumefactive Demyelination.
Chia-Chen Tsai, Joshua D Lee, Tychicus Chen

Neurohospitalist· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Perceptions of Integrating Meditation-based Interventions in Office-based Opioid Treatment with Buprenorphine: A Mixed-methods Survey.
Babak Tofighi, Christina Marini, Joshua D Lee, Eric L Garland

J Addict Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial.
Babak Tofighi, Beita Badiei, Ryan Badolato, Crystal Fuller Lewis, Edward Nunes, Joshua D Lee

J Addict Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder.
Matisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, Martina Pavlicova, Patricia Novo, Joshua D Lee

J Addict Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Misclassification of overdose events in the X:BOT study - Authors' reply.
Joshua D Lee, Edward V Nunes, Paul Van Veldhuisen, Robert Lindblad, John Rotrosen

Lancet· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial.
Noel Vest, Kevin Wenzel, Tse-Hwei Choo, Martina Pavlicova, John Rotrosen, Joshua D Lee

Am J Addict· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17.
Sungwoo Lim, Teena Cherian, Monica Katyal, Keith S Goldfeld, Ryan McDonald, Joshua D Lee

Addiction· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provider and administrator attitudes and experiences with implementing telebuprenorphine during the COVID-19 pandemic: a mixed-methods survey.
Babak Tofighi, Rosalina Lopez, Gabriela Araujo, Joshua D Lee, Elizabeth A Samuels

J Subst Use· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes.
Amanda M Bunting, Noa Krawczyk, Tse-Hwei Choo, Martina Pavlicova, Jennifer McNeely, Joshua D Lee

J Subst Abuse Treat· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid Use Disorder Treatments: An Evidence Map.
Allison Sugarman, Alexandria Vittitow, Anna Cheng, Mia Malone, Ryan McDonald, Kathleen Garrity, Joshua D Lee

Drug Alcohol Depend· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional study.
Elizabeth C Saunders, Milan F Satcher, Laura B Monico, Ryan D McDonald, Sandra A Springer, Joshua D Lee

Health Justice· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial.
Joshua D Lee, Edward V Nunes, Patricia Novo, Jeanine May, Abigail Matthews

J Addict Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone.
Miranda G Greiner, Matisyahu Shulman, Jennifer Scodes, Tse-Hwei Choo, Martina Pavlicova, Joshua D Lee

Subst Use Misuse· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis